Introduction
Mallory-Denk Bodies (MDBs), which are an intracellular deposition of misfolded protein in ballooned hepatocytes, consist of abnormally phosphorylated, ubiquitylated, and crosslinked keratins or non-keratin K18 and 8, and p62 components (Zatloukal et al., 2007; Caldwell et al., 2010; Basaranoglu et al., 2011; Haybaeck et al., 2012) . Ballooning of hepatocytes is induced by oxidative stress, and both ballooning of hepatocytes and MDBs are two characteristics of ongoing inflammation (Basaranoglu et al., 2011) . MDBs are prevalent in various hepatic diseases including the hepatitis B and C virus (HBV and HCV), alcoholic hepatitis (AH), non-alcoholic steatohepatitis (NASH), drug injuries and hepatocellular carcinoma (HCC) (Zatloukal et al., 2007; Basaranoglu et al., 2011) . Balloon hepatocytes forming MDBs are progenitor preneoplasia cells . In the DDC fed mouse model where liver cells proliferate, MDBs form and later, after DDC withdrawal, HCCs develop (Oliva et al., 2008) . Three new mechanisms of MDB formation (epigenetic mechanisms, shift from the 26S proteasome to the immunoproteasome and activation of Toll-like signaling) have recently been identified . However, the detailed molecular events involved in liver MDB formation, especially in human liver disease development, remains undetermined.
Toll-like receptors (TLRs) are a family of pattern-recognition receptors (PRRs) that play a critical role in chronic liver disease by recognizing pathogen-associated molecular patterns (PAMPs) (Roh & Seki, 2013) . By recognizing corresponding ligands (bacteria, viruses, fungi, parasites, etc.) , the TLRs signaling pathways are orchestrated via myeloid differentiation factor 88 (MyD88)-dependent or the TRIF-dependent pathway which initiates innate immune responses and priming antigen-specific acquired immunity (Takeuchi & Akira, 2010) . Except for TLR3, all TLRs activate the MyD88-dependent pathway, recruit the IRAK family of protein kinases, and lead to the activation of TRAF6 (Akira & Takeda, 2004) . TRAF6 induces the activation of the IKK complex and leads to activation of NFκB, or activates AP-1 by TAK1 (Roh & Seki, 2013) . In contrast, TLR3 and TLR4 can utilize the MyD88-independent, TRIF-dependent pathway. Subsequently, TRIF associates with TRAF 3 and TRAF 6 to activate the TBK1 and IKK complex, which results in the activation of interferon inducible genes and NFκB respectively (Takeuchi & Akira, 2010) . These transcription factors induce the expression of various inflammatory cytokines (TNF-α and IL-6, etc.), interferons, and chemokines. TLRs play key roles in the pathogenesis of a variety of liver diseases (Seki & Brenner, 2008) , including the formation of HCC when mice are fed ethanol and LSP Machida et al., 2012; Chen et al., 2013) . Activation of the resident liver cells, such as Kupffer cells, is one of the key elements in the pathogenesis of AH and NASH, producing inflammatory cytokines and chemokines to initiate the inflammatory cascade (Petrasek et al., 2013a) . Kupffer cells express all TLRs with the exception of TLR5 at mRNA and protein levels while hepatic stellate cells also express all TLRs at transcriptional levels in quiescent and activated states (Wang et al., 2009) . Hepatocytes express all TLRs at the transcriptional level, while the expression levels of TLR2, TLR3, TLR4 and TLR5 are very low in vivo (Isogawa et al., 2005) except in the Machida model (Machida et al., 2009; Machida et al., 2012) . However, gene expression of Toll-signaling in ballooned hepatocytes (MDB-forming cells) is still unknown.
The Chemokine CXCL12 (SDF-1α) is a broadly expressed CX chemokine, and the predominant CXCL12 receptor is the CX chemokine receptor 4 (CXCR4), a protein frequently over-expressed on the surface of human tumor cells of epithelial origin (Kaifi et al., 2005; Schimanski et al., 2005) . CXCL12 can also bind another chemokine receptor CXCR7, which is present on the surface of many different malignant cell types (Burns et al., 2006) , and tumor-associated blood vessels (Miao et al., 2007) . Recently FAT10, which is over-expressed in various cancers including liver tumors (Lee et al., 2003; Qing et al., 2011) , was found to activate NFκB which in turn up regulates CXCR4/7 in NeHepLxHT and HCT116 cells (Gao et al., 2014) . This raises an interest for us to explore the relationship of NFκB with CXCR4/7 induced by Toll-like signaling in liver patients with MDBs presents.
In this study, gene expression of TLRs signaling was investigated for the first time in the livers of AH and NASH patients' biopsies. Striking similarities and obvious differences in the activation of Toll-like signaling in AH and NASH patients were studied. Interestingly, CXCR4 and CXCR7 were both significantly up regulated in the patients' livers in FAT10 over-expressing hepatocytes.
Materials and Methods

Biopsies
Human archived formalin-fixed paraffin-embedded (FFPE) liver biopsies from patients who had alcoholic hepatitis (AH; n=3) and non-alcoholic steatohepatitis (NASH; n=3) were obtained from Harbor UCLA hospital archives. In all the cases liver forming MDBs were present except in the normal control livers (Control; n=3). The biopsy sections were cut 4 μm thick.
RNA isolation and cDNA synthesis
RNA isolation of FFPE sections of human liver biopsies was performed as we previously described (Liu et al., 2014) . The quality and yield of the resulting total RNAs were assessed with an absorbance reading at 260 nm (A 260 ) using a spectrophotometer (Thermo). Synthesis of first-strand cDNAs was performed with the above mentioned total RNA (250ng), and random hexamer primers using SuperSript III First-Strand Synthesis SuperMix following the instruction (Invitrogen).
Quantitative Real-time PCR analysis
Real-time PCR was performed using the Fast SYBR Green Master Mix on a StepOnePlus ™ Real-time PCR System (Applied Biosystems) with a primer concentration of 200 nM. Primer sequences and the related gene Accession Number are listed in Table I . Reaction conditions consisted of 95°C for 20 sec, followed by 40 cycles of 95°C for 3 sec, 60 °C for 30 sec. Single PCR product was confirmed with the heat dissociation protocol at the end of the PCR cycles. Human α-tubulin was used as control to normalize the starting quantity of RNA. The target mRNA abundance in each sample was normalized to its endogenous control level and the relative mRNA expression levels were analyzed using the ΔΔC T method. Reaction of each sample was performed in triplicate.
Immunohistochemical staining
Formalin fixed, paraffin embedded tissue slides were double stained for CXCR4 (Abcam Inc., Cambridge MA) and Ubiquitin (Millipore, Temecula CA). A second set of slides was double stained for CXCR7 (Millipore, Temecula CA) and Ubiquitin (Millipore, Temecula, CA. CXCR4 and CXCR7 were detected using the second antibody donkey anti rabbit Alexa Fluor 488 (Jackson Immuno Research Laboratories Inc. West Grove, PA). Ubiquitin was detected using the second antibody donkey anti mouse Alexa Fluor 594 (Jackson Labs. West Grove, PA). All slides were stained with the nuclear stain DAPI (Molecular Probes, Eugene, OR). The slides were examined with a Nikon 400 fluorescent microscope.
Statistical analysis
Statistical significance was determined using the t-test and One Way ANOVA test with SigmaStat software. P values less than 0.05 were considered statistically significant. Regression plots were constructed using the Sigmaplot software. All data were presented as the mean ± S.E.M and were representative of at least two-independent experiments done in triplicate.
Results
TLR3 and TLR4 are significantly up regulated both in the livers of AH and NASH patients
An increased mRNA expression of TLR2 and TLR4 were observed in mice re-fed DDC , implying the involvement of TLR signaling in liver MDB formation. To further examine how gene expression of Toll-like signaling was changed in human chronic liver diseases, where MDB formation progresses to tumor, TLRs were measured using real-time PCR analysis. Human liver biopsies, including normal liver tissue, AH and NASH biopsies were utilized in this assay. As expected, all TLRs mRNA tested were up regulated both in the livers of AH and NASH biopsies ( Figure 1 ). Among them, approximately 3-and 7-fold (respectively, p<0.05) up regulation levels of TLR3 and TLR4 mRNAs were observed in the livers of AH biopsies when compare to other TLR mRNAs (Fig. 1A) . In contrast to AH, TLR3 and TLR4 mRNAs were induced to 3-and 2.6-fold levels (respectively, p<0.05) in the livers of NASH patients (Fig. 1B) . These results suggest that both TLR3 and TLR4 play an important role in the pathogenesis in AH and NASH patients. Other TLR mRNAs, including TLR2, TLR5 and TLR8, were also up regulated to various degrees in the livers of AH and NASH with MDBs present (Figure 1 ).
The MyD88-dependent pathways were markedly activated in the livers of both AH and NASH biopsies
Gene expression of TLRs signaling downstream molecules were further examined by realtime PCR analysis. Similar to some previous observations in mice , the mRNA levels of MyD88, TRIF, IRAK1, IRAK4, TAK1, TRAF3, TRAF6 and IRF7 were all up regulated to various degrees in the AH patients liver biopsies (Fig. 2A) . The MyD88 mRNA in the AH biopsies was induced by up to a 15-fold expression, while IRF3 mRNA showed almost no changes. This might suggest that the MyD88-dependent pathway is the main pathway in AH patients with MDBs present. In contrast to AH, mRNAs of MyD88, IRF3 and IRF7 were all significantly up regulated in the livers of NASH biopsies (Fig. 2B) , suggesting both MyD88-dependent and MyD88-independent pathways are up regulated in the NASH patients. These results clearly indicated that MyD88-dependent pathway is markedly up regulated both in the livers of AH and NASH patients with MDB formation.
Liver MDB formation which may progress to HCC is involved in the NFκB-CXCR4/7 pathway in FAT10 over-expression hepatocytes Recent research showed that FAT10 is markedly up regulated in the livers of AH, cirrhosis and NASH biopsies with MDBs present (Liu et al., 2014) . FAT10 activates nuclear factor κB (NFκB), resulting in up regulation of the chemokine receptors CXCR4 and CXCR7 in NeHepLxHT cells (Gao et al., 2014) . Therefore, the mRNA levels of NFκB p65, CXCR4 and CXCR7 were measured in the livers of AH and NASH biopsies by real-time PCR. As expected, the up regulation of mRNA expression of p65, CXCR4 and CXCR7 were observed in the patients' livers ( Figure 3) . Interestingly, the CXCR7 pathway was significantly up regulated in patients with AH and the CXCR4 and p65 expression were significantly up regulated in patients with NASH (Figure 3 ), indicating that CXCR4/7 plays a role in liver MDB formation. Immunohistochemical staining showed that MDB forming balloon hepatocytes in AH liver biopsies were expressing CXCR7 in the liver cytoplasm and co-localizing with ubiquitin in MDBs (Figure 4) . These results indicate that the NFκB-CXCR4/7 pathway is involved in liver MDB formation.
Discussion
Chronic liver disease such as alcoholic hepatitis (AH) and non-alcoholic steatohepatitis (NASH) represents a significant cause of morbidity and mortality worldwide (Burroughs & McNamara, 2003; Minino et al., 2007) . Recognition of Toll-like receptors (TLR) signaling, which produce inflammatory cytokines and chemokines to initiate the inflammatory cascade, is the key component involved in activation of innate immunity in AH and NASH (Petrasek et al., 2013a) . The TLR signaling pathways are up regulated in various chronic liver diseases. Different cell types in the liver express different TLRs (Seki et al., 2011) . TLR2 and TLR4 mRNA are also up regulated in the livers of DDC re-fed mice (BardagGorce et al., 2010) and in primary hepatocyte cultures where MDBs form (Yuan et al., 2000; Nan et al., 2005; Nan et al., 2006) . TLRs signaling are up regulated in rats fed ethanol intragastrically, especially when the blood alcoholic levels are high (Khachatoorian et al., 2013) . However, information about the pathologic significance of TLRs signaling in AH and NASH patients with MDBs present is still unknown.
To provide clinical evidence of gene expression of the TLRs signaling in the livers of AH and NASH patients with MDB-forming hepatocytes, biopsies from these patients were examined by real-time PCR analysis. An interesting observation is that the mRNA levels of TLR3 and TLR4 were much higher than other TLRs both in the livers of AH and NASH biopsies. Why TLR3 and TLR4 are significantly up regulated in the AH and NASH patients and what are the biological functions or mechanism of up regulation of these two TLRs in liver MDB formation? A possible reason is that TLR3 and TLR4 recognize different ligands where TLR3 recognizes viral double-strand RNA and poly (I: C) while TLR4 recognizes the endotoxin from Gram-negative bacteria, which can both induce an inflammatory response and antiviral immune response (Zhao et al., 2008; Ganz & Szabo, 2013) . Ample epidemiological evidence suggests that there is a strong connection between hepatitis C virus (HCV) and AH, where the prevalence of HCV is significantly higher among alcoholics than in the normal population (Heintges & Wands, 1997) . Second, alcohol may enhance the replication of HCV and thus increase the expression of viral RNA and proteins, resulting in more severe HCV-induced liver injury (Brechot et al., 1996) . So the increase of viral RNA and protein levels might induce the up regulation expression of TLR3 mRNA to initiate the antiviral immune response. Additionally, we noticed that TLR7 and TLR8 whose ligands are viral single-stranded RNA, were also slightly up regulated in AH biopsies.
The activation of both MyD88-dependent and MyD88-independent pathways were reported in mouse models of AH and NASH (Hritz et al., 2008; Csak et al., 2011a) . The downstream molecules of TLRs in AH and NASH were further investigated by real-time PCR analysis. A significantly up regulated expression of MyD88 mRNA (15 fold, p<0.05) was observed in the livers of AH patients, indicating that the MyD88-dependent pathway was activated. To understand liver tumorigenesis, it is very important to analyze which cell types are involved in the process. Kupffer cells may be the major cells expressing TLRs in the liver (Roh & Seki, 2013) . A recent study showed that TLR4 signaling in AH is mediated via the TRIF/ IRF3-dependent, MyD88-independent pathway using the Lieber-DeCarli model of AH (Petrasek et al., 2013b) . However, we did not observe the obvious changes of IRF3 and IRF7 mRNA, nor TRIF mRNA in the livers of AH biopsies. Our observation suggests that the MyD88-dependent pathway is the main pathway in AH patients with MDBs present, different from the observation in Kupffer cells. The possible cause may be the differences of cell types involved, since all cases studied by immunohistochemistry showed an increased expression of TLR4 in the cytoplasm of the liver cells , including the balloon cells forming MDBs, and including incorporation of TLR4 within the MDB. We also noticed that the mRNA level of TLR4 was higher than TLR3 in the livers of AH patients, probably suggesting that inflammatory response is the main pathway involved compared to antivirus immune response in the hepatocytes.
It was observed that MyD88, IRF3 and IRF7 mRNAs were all significantly up regulated in the livers of NASH biopsies, which was different from AH. Also it was noted that the mRNA level of TLR3 is slightly higher than TLR4 in the livers of NASH patients, indicating both TLR4 MyD88-dependent and TLR3 MyD88-independent pathways were activated in the pathogenesis of NASH development in MDB formation. The differential induction of MyD88-dependent and MyD88-independent pathway in AH and NASH patients may relate to the differences in dynamics between these two disease (Petrasek et al., 2013a) . This is because excessive consumption of alcohol may induce liver inflammation in a shorter period of time than the consumption of a steatogenic diet, which results in the development of NASH (Csak et al., 2011a; Csak et al., 2011b) . Secondly, the development of NASH involves insulin resistance and an endocrine crosstalk between adipose tissue and the liver, which inhibits the TLR4/MyD88-dependent pathway in macrophages (Mandal et al., 2010) . However, it is still uncertain as to how adiponectin, an anti-inflammatory cytokine secreted by adipose tissue, contributes to the MyD88-dependent pathways of NASH in MDB-forming hepatocytes. Strangely, we did not observe the significant up regulation of TRIF mRNA in the livers of AH and NASH patients, although there was a marked increase of IRF3 and IRF7 mRNAs in the livers of NASH biopsies.
After activation by ligands, TLRs triggers a cascade of downstream adaptor signaling and ultimately activate the transcription factors NFκB and chemokines. The chemokine CXCL12 appears to be of particular importance in tumor biology, and interaction of CXCL12 with its receptor CXCR4 and CXCR7 is found to be highly expressed in tumor and tumor-endothelial cells (Miao et al., 2007; Burger & Peled, 2009; Hattermann et al., 2010) . The CXCL12/CXCR4 and CXCL12/CXCR7 axis are important factors in tumor initiation, promotion, progression, metastasis and cancer cell survival (Vandercappellen et al., 2008; Marechal et al., 2009) . However, the biological significance of CXCR4 and CXCR7 in liver MDB-forming cells is still unknown. Therefore, the transcript regulation of CXCR4 and CXCR7, with NFκB p65 were investigated by real-time PCR analysis in the livers of AH and NASH biopsies. In our series, CXCR4 mRNA was significantly up regulated in patients with NASH, while CXCR7 mRNA was significantly up regulated in the patients with AH, suggesting a different role played by these two receptors in NASH and AH. The reasons for the differences between CXCR4 and CXCR7 mRNA levels in AH and NASH patients probably result from CXCR4 and CXCR7 having different CXCL12 binding domains and distinct roles during disease development (Sierro et al., 2007) , although both of them can bind to CXCL12. Another reason may be because unlike CXCR4, CXCL12 activation of CXCR7 does not induce calcium mobilization and cell migration but rather results in a proliferative effect and increased adhesion properties (Burns et al., 2006; Wang et al., 2008) . Although we observed the differential expression of CXCR4 and CXCR7 in the livers of AH and NASH patients, whether they are involved in MDB-forming hepatocytes needs to be determined.
Recently, we observed the marked up regulation expression of FAT10 in the livers of AH and NASH patients (Liu et al., 2014) . FAT10 expression is induced by interferon (IFN)-γ and tumor necrosis factor α (TNFα) in tumor cells (Lukasiak et al., 2008; Ren et al., 2011) and activates NFκB, which in turn un regulates CXCR4/7 in NeHepLxHT and HCT116 cells (Gao et al., 2014) . Interestingly, the NFκB binding site was found at the FAT10 promoter region (Zhang et al., 2006) , while TNFα-dependent induction of FAT10 expression requires NFκB activation (Ren et al., 2011) . The interferon sequence response element (ISRE) located on the FAT10 promoter region activates NFκB in response to IFNγ . These findings indicate a potential feedback system in chronic inflammatory-associated microenvironments such as in AH and NASH. The cytokine TNF-α or chemokines induced by the activation of TLRs signaling induce FAT10, which activates NFκB. This in turn promotes the FAT10 transcription by binding to FAT10 promoter sites . NFκB has recently been found to bind a transcript factor for both CXCR4 and CXCR7 receptors (Tarnowski et al., 2010) , and CXCR4 and CXCR7 can also activate NFκB (Huang et al., 2009) , further suggesting CXCR4 and CXCR7 may sustain NFκB activity by a feedback system. We confirmed that the CXCR4 and CXCR7 mRNAs were up regulated in MDB-forming (FAT10-over-expressing) hepatocytes within this NFκB network. Based on these findings, transcription up regulation of TLR signaling and CXCR4/7 which results in liver MDB formation is shown in Figure 5 . The gene expression changes induced by TLR signaling, inducing the up regulation of FAT10 and CXCR4/7, may be a novel mechanism in liver MDB formation. The further elucidation of the relationship of FAT10 and CXCR4/7 in the inflammatory pathway including TLR pathway will provide a better understanding of chronic liver disease pathogenesis and MDB formation.
In summary, our data demonstrates for the first time the gene expression changes of TLR signaling in the livers of AH and NASH patients where MDBs formed. Striking similarities and obvious differences were observed in the TLR signaling activation, where the MyD88-dependent pathway was significantly up regulated in patients with AH, while both MyD88-dependent and MyD88-independent pathways were up regulated in patients with NASH. The prominent transcription up regulation expression of CXCR4 and CXCR7 were observed in FAT10 over expressing hepatocytes, indicating that CXCR4 and CXCR7 may be attractive targets for AH and NASH therapy. The data provide evidence to further understand human liver disease and MDB formation.
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